RSS

acquisition

Manufacturer of small molecule innovator and generic active pharmaceutical ingredients (APIs), Cambrex, has completed its acquisition of dosage form contract development and manufacturing organisation (CDMO), Halo Pharma. more

News

Global biopharmaceutical outsourcing services provider, PCI Pharma Services, has acquired California-based Sherpa Clinical Packaging — a provider of clinical trial supply services. more

News

WDB Medical Data (WDBMD) — a global provider of contract research organisation and R&D services to the biopharma and medical device industry — has acquired DZS Clinical Services, which provides clinical development and data analytic services. more

News

Biotech company owned by PPF Group, Sotio, has announced the completion of its acquisition of Cytune Pharma. more

News

Catalent, provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has completed its tender offer for all outstanding shares of Juniper Pharmaceuticals. more

News

Novo Nordisk, global healthcare company, has acquired all of the shares of a University of Bristol spin-out company — Ziylo — giving it full rights to a glucose blinding molecule platform to develop glucose responsive insulins. more

News

Taking Prime position.jpg

Mila Dubas / Shutterstock.com

As the pharma market is rocked by the news of Amazon’s acquisition of PillPack — the online pharmacy — we briefly take a look at the history of the e-commerce giant and what impact its move into pharma may have on the traditional space. more

Opinion

The UK division of global logistics provder, Yusen Logistics, has acquired ILG — and e-commerce delivery and fulfilment specialist. more

News

Investor in healthcare technology and services companies — Genstar Capital — has acquired global provider of eCOA and eConsent solutions for the life sciences industry — CRF Health. more

News

Investment-type holding company of SK Group, SK Holdings, has come to an arrangement where it will acquire 100% of the ownership interests in AMPAC Fine Chemicals (AFC) — a contract development and manufacturing organisation (CDMO). more

News

International healthcare services provider, UDG Healthcare, has acquired New York-based disruptive creative communications agency, Create NYC, and strategic commercialisation consulting and analytics business, SmartAnalyst, for up to $82.4 million. more

News

Catalent, global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, has signed an agreement for the acquisition of Juniper Pharmaceuticals. more

News

Amazon

Hadrian / Shutterstock.com

Amazon, the online shopping goliath, has confirmed its entrance into the healthcare market by announcing its proposed acquisition of PillPack — an online pharmacy that offers pre-sorted doses of medication delivered to patients’ homes. more

News

European plastics manufacturer, SGH Healthcaring, has acquired two French companies, Rovipharm and RR Plastiques, which aligns with the company’s growth roadmap. more

News

Sanofi has acquired all outstanding shares, warrants and convertible bonds of Ablynx, following the expiration of the squeeze-out procedure. more

News

CDMO, Recipharm, has acquired Sanofi’s manufacturing centre and business located in Holmes Chapel, which will provide the company with a platform to take advantage of the growing respiratory drug market. more

News

Global life sciences company, LabCorp, has acquired scientific process outsourcing company, Sciformix — which will become a part of Covance, LabCorp’s drug development business. more

News

Softbox (global innovator and provider of temperature control packaging) has announced its acquisition of Cold Tech Systems, further expanding its presence in Latin America. more

News

Ardena, a contract development and manufacturing organisation (CDMO), has acquired Syntagon, a contract manufacturer of novel active pharmaceutical ingredients (APIs) and excipients. more

News

Healthcare solutions provider, Novartis, is set to gain further ground in the area of gene therapy through its agreement to acquire AveXis — US-based clinical stage gene therapy company — for $8.7 billion. more

News